1. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. (10th January 2017) Authors: McGarry, Andrew; McDermott, Michael; Kieburtz, Karl; de Blieck, Elisabeth A.; Beal, Flint; Marder, Karen; Ross, Christopher; Shoulson, Ira; Gilbert, Peter; Mallonee, William M.; Guttman, Mark; Wojcieszek, Joanne; Kumar, Rajeev; LeDoux, Mark S.; Jenkins, Mary; Rosas, H. Diana; Nance, Martha; Bigla... Journal: Neurology Issue: Volume 88:Number 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. (10th January 2017) Authors: McGarry, Andrew; McDermott, Michael; Kieburtz, Karl; de Blieck, Elisabeth A.; Beal, Flint; Marder, Karen; Ross, Christopher; Shoulson, Ira; Gilbert, Peter; Mallonee, William M.; Guttman, Mark; Wojcieszek, Joanne; Kumar, Rajeev; LeDoux, Mark S.; Jenkins, Mary; Rosas, H. Diana; Nance, Martha; Bigla... Journal: Neurology Issue: Volume 88:Number 2(2017) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. E8 Trunk sway relates to gait and mobility measures and provides insight into increased fall risk in younger individuals with huntington's disease. (13th September 2016) Authors: Kegelmeyer, Deb; Kloos, Anne; Fritz, Nora; Chaudhari, Ajit; Kostyk, Sandra Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87(2016)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. H45 The steps tool: an easy to use assessment measure that highlights impairments impacting stair safety. (September 2018) Authors: Kegelmeyer, Deb; Kostyk, Sandra; Kline, David; Ambrogi, Katherine; Kloos, Anne Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. J05 Interim results from cohort 1 of the double-blind, dose-escalation phase I/II clinical trial of amt-130 (HD-genetrx-1) for early-stage huntington's disease (HD). (12th September 2022) Authors: Furr Stimming, Erin; Sung, Victor; Testa, Claudia; Kostyk, Sandra; Ross, Christopher A; Samii, Ali; Geschwind, Michael D; Hall, Deborah; Dayalu, Praveen; Lonser, Russell; Elder, Brad; Larson, Paul S; Cooper, David L; Clarkin, Marcie; Ali, Talaha M; Dolmetsch, Ricardo E Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. J09 An update on the proof-HD phase 3 trial: pridopidine's outcome on function in huntington. (12th September 2022) Authors: Reilmann, Ralf; Feigin, Andrew; Rosser, Anne; Kostyk, Sandra; Geva, Michal; Gershoni-Emek, Noga; Boot, Diderik; Cohen, Yael; Goldberg, Y Paul; Hayden, Michael R Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P3‐134: MOTOR AND COGNITIVE PROFILES DIFFER BETWEEN LEWY BODY DEMENTIA AND PARKINSON'S DISEASE IN A PAIRED COMPARISON STUDY. (1st July 2014) Authors: Scharre, Douglas W.; Chang, Shu‐ing; Nagaraja, Haikady; Park, Ariane; Agrawal, Punit; Adeli, Anahita; Linder, Shannon; Kloos, Anne; Kegelmeyer, Deborah; Fritz, Nora; Kataki, Maria; Kostyk, Sandra Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 18 Page Start: P677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗